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Abstract
Oral cavity represents an ideal environment for the microbial cell growth, persistence, 
and dental plaque establishment. The presence of different microniches leads to the 
occurrence of different biofilm communities, formed on teeth surface, above gingival 
crevice or at subgingival level, on tongue, mucosa and dental prosthetics too. The healthy 
state is regulated by host immune system and interactions between microbial community 
members, maintaining the predominance of “good” microorganisms. When the com-
plexity and volume of biofilms from the gingival crevice increase, chronic pathological 
conditions such as gingivitis and periodontitis can occur, predisposing to a wide range 
of complications. Bacteria growing in biofilms exhibit a different behavior compared 
with their counterpart, respectively planktonic or free cells. There have been described 
numerous mechanisms of differences in antibiotic susceptibility of biofilm embedded 
cells. Resistance to antibiotics, mediated by genetic factors or, phenotypical, due to bio-
film formation, called also tolerance, is the most important cause of therapy failure of 
biofilm-associated infections, including periodontitis; the mechanisms of tolerance are 
different, the metabolic low rate and cell’s dormancy being the major ones. The recent 
progress in science and technology has made possible a wide range of novel approaches 
and advanced therapies, aiming the efficient management of periodontal disease.
Keywords: dental plaque biofilm, periodontitis, host defense mechanisms, resistance 
mechanisms, therapeutic approaches
1. Introduction
Oral cavity represents an ideal environment (e.g., appropriate temperature and nutrients) 
for the microbial cell growth, survival and persistence, and subsequent dental plaque 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
biofilm establishment. The exact number of species from the oral plaque is not known, 
because some of them are not cultivable, but it is estimated to be between 700 and 1000 
species, reaching densities of 108 bacterial cells/mg, much of them being uncultivable [1]. 
However, bacteria are the most numerous group in the oral microbiota, accompanied by 
a diverse collection of archaea, fungi, protozoa, and viruses. The oral microorganisms are 
generally commensal species, maintaining relationships with the host based on mutual 
benefits. They do not produce disease, but instead impede pathogenic species to adhere to 
mucosal surfaces [2, 3].
Dental plaque biofilm represents a polymicrobial community that remains relatively stable in 
health, consisting in species belonging to Streptococcus, Actinomyces, Veillonella, Fusobacterium, 
Porphyromonas, Prevotella, Treponema, Neisseria, Haemophilus, Eubacteria, Lactobacterium, 
Capnocytophaga, Eikenella, Leptotrichia, Peptostreptococcus, Staphylococcus, and Propionibacterium 
genera.
The dental plaque biofilm formation follows many stages and begins at 1 h after washing, 
when the tooth surfaces are covered by an organic “pellicle” composed from salivary glyco-
proteins, carbohydrates and immunoglobulins, which are adsorbed on the hydroxyapatite 
surface through electrostatic interactions between calcium ions and phosphate groups with 
the oppositely charged groups of the macromolecules from the saliva. In a second stage, bac-
teria adhere to the pellicle and between them through the interaction between specialized 
structures or adhesins (glycocalyx, capsule, and fimbriae) with complementary receptors. The 
first colonizers are gram-positive cocci (Str. mutans, Str. mitis, Str. sanguis or Str. oralis, Rothia 
dentocariosa, or Staphylococcus epidermidis), gram-positive rods, actinobacteria (Actinomyces 
israelis and A. viscosus) and few gram-negative cocci [4]. The attached species secrete exopoly-
mers such as glucans that contribute to the development of biofilm matrix and allow associa-
tion of other species. Although initially the oral cavity offers an aerobic condition, oxygen is 
rapidly consumed by the aerobic bacteria (e.g., Neisseria spp.) or facultative anaerobic (e.g., 
Streptococcus and Actinomyces spp.), which are first colonizers creating appropriate conditions 
for the survival of obligate anaerobe species. When biofilm reaches maturity, the oral cavity 
becomes colonized predominantly by anaerobic bacteria [5].
In the oral cavity, the presence of different microenvironments leads to the occurrence of 
different biofilm communities, like those formed on the surface of teeth above the gingival 
crevice (the supragingival plaque) or at the subgingival level (the subgingival plaque), on 
the tongue, on the mucosal surfaces, or biofilms developed on dental prosthetics and fill-
ings. Some microbial species are better adapted to some location. For example, based on 
their oxygen requirements, species could be classified as obligate aerobes, obligate anaer-
obes (as Veillonella and Fusobacterium), facultative anaerobes (as most streptococci and 
Actinomyces), and microaerophilic species that prefer low concentrations of O
2
 (from 2 to 
10%) and capnophilic (species that grow best at high CO
2
 concentrations, from 5 to 10%, as 
Neisseria) [3].
When the complexity and volume of biofilms located in the gingival crevice increase, path-
ological conditions such as periodontitis or chronic gingivitis can occur. Literature of the 
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last decades has shown that almost all forms of the periodontal disease are consequences 
of the chronic, nonspecific or specific bacterial infections. If in the healthy individuals, the 
oral biofilms are comprised mainly of gram-positive facultative anaerobes (Streptococcus 
anginosus and A. naeslundii), in the above mentioned pathologic conditions, the percentage 
of gram-negative anaerobic bacteria increases and may include Aggregatibacter (previously 
Actinobacillus) actinomycetemcomitans, Porphyromonas gingivalis, P. intermedia, Bacteroides for-
sythus, Campylobacter rectus, Eikenella sp., Peptostreptococcus micros, Streptococcus intermedius, 
Prevotella sp., Fusobacterium sp., Capnocytophaga sp., Veillonella sp., Treponema and other on-cul-
tivable spirochetes, and the bacterial counts associated with the disease are up to 10(5) times 
larger than those of the same species found in healthy individuals [6, 7].
Perhaps, the three best-studied periodontal pathogens are Porphyromonas gingivalis, Aggregatibacter 
actinomycetemcomitans, and, more recently, Bacteroides forsythus, all three carrying pathogenicity 
islands and having the ability to secrete a number of virulence factors, including invasion of gingi-
val epithelial cells and an abundant array of extracellular proteases. The last ones are responsible 
for the increase in vascular permeability and in the flow of gingival crevicular fluid (GCF), thus 
providing a rich source of nutrients for the subgingival plaque community.
Porphyromonas gingivalis is one of the most important periodontal pathogens, exhibiting the 
ability to adhere and invade epithelial tissue of the oral cavity in vitro. Aggregatibacter (A.) 
actinomycetemcomitans is associated with periodontal disease in preteen ages. Fusobacterium 
nucleatum is an important periodontal agent, especially in the rapid and progressive peri-
odontal disease forms. Prevotella intermedia is black-pigmented, while Bacteroides (B.) for-
sythus an unpigmented gram-negative bacterium; B. forsythus has several virulence factors, 
including the production of trypsin-like proteases and polysaccharides, the ability to pen-
etrate the host cell, or inducing of apoptosis. Capnocytophaga species are involved in the 
onset of the juvenile periodontal disease and in the periodontal disease of adults. These 
bacteria produce pro-inflammatory lipopolysaccharides and extracellular proteases that 
could destroy sIgA immunoglobulins. Prevalence of Peptostreptococcus micros in advanced 
periodontitis in adults has been reported as 58–63%. It was also positively associated with 
dental implant failure. Spirochetes were observed in a greater proportion in patients with 
periodontal disease than in healthy individuals [8]. Two important spirochetes species, i.e., 
Troponema vincentii and T. denticola, are also involved in periodontal disease. Both produce 
pro-inflammatory lipopolysaccharides and unusual metabolic products, such as indole, 
hydrogen sulfide and ammonia that are potentially toxic to the host cells.
Besides the microbial component, genetic, physiological, and behavioral factors are also 
involved in the pathogenesis of periodontal disease. Some people may be genetically suscep-
tible to periodontal disease, but the genetic background involved is not clear. The hormonal 
changes associated with teen age and pregnancy could contribute to gingival enlargement. 
Smoking is among the factors that increase the probability to develop a periodontal disease. In 
smokers, reduced gingival blood flow, impaired wound healing, and increased production of 
inflammation-mediating cytokines were observed comparing with healthy persons. Smoking 
seems to increase the severity of periodontal disease, but also the response of the gingival 
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 tissues to periodontal therapy is reduced, fact that contributes to a greater incidence of refrac-
tory disease and to the risk to lose teeth. Regarding age, the researches indicate that older people 
have the highest rates of periodontal disease. Other factors which may contribute to evolution 
of periodontitis are diet, stress, obesity, and some other underlying diseases such as diabetes, 
cardiovascular disease, osteoporosis, and rheumatoid arthritis. Certain medications could also 
be inappropriate for the evolution of periodontal disease. Also, a bad oral hygiene, tooth decay 
and tooth positioned incorrectly may also increase the risk of periodontal disease [9].
The management and therapy of periodontal diseases may be diverse and is usually adjusted 
depending on particularities of each case/patient (Figure 1). Since periodontal disease occurs 
when a bacterial biofilm (dental plaque) adheres to the boundary between the teeth and 
gingiva, causing chronic inflammation and progressively destroying the periodontal tis-
sue that supports the teeth, the periodontal treatment involves scaling and root planning, 
which mechanically removes the causative bacteria biofilm together with the necrotic cemen-
tum from the surface of the tooth root. Appropriate application of this therapy eliminates 
periodontal tissue inflammation and stops the process of destruction of the same tissue. 
However, removing the cause of the disease does not regenerate the lost periodontal tissue 
to its original state [10].
The main approaches considered in the current therapeutic procedures include the following:
(1) Nonsurgical periodontal therapy aims in motivating and instructing the patient in adequate 
self-care, followed by periodical re-evaluation of the oral hygiene status. The primary goal 
of nonsurgical periodontal therapy is to control microbial periodontal infection by removing 
bacterial biofilm, calculus and toxins from the involved periodontal root surfaces [11].
A new nonsurgical therapy is the ozone-therapy; the disinfection power of ozone over other 
antiseptics makes the use of ozone in dentistry a very good alternative and/or an additional 
disinfectant to standard antiseptics. Due to safety concerns, initially only dissolved ozone in 
water and ozonated oils were recommended, but a new device used for the gas application 
Figure 1. Periodontitis management—innovative strategies for reversing the chronic infectious and inflammatory 
condition.
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with a suction feature allows now its safe intra-oral use, with better diffusion even in the den-
tal hard tissues, for its healing and tissue regeneration properties, being indicated in all stages 
of gingival and periodontal diseases [12].
(2) Management of local plaque-retentive factors which refer to mal-positioned teeth, overhanging 
restorations, crown and bridgework, partial dentures and fixed and removable orthodontic 
appliances that can increase the risk of periodontal disease and can also prevent successful 
treatment and resolution of associated pockets. Local irritation and plaque retention caused 
by untreated carious lesions, subgingival and approximate overhanging crown margins can 
affect the attachment loss at patients with chronic periodontitis [13].
(3) Antimicrobial medication may refer to: full mouth disinfection (consisting in the instrumen-
tation of all periodontal pockets in two steps within 24 h in combination with the adjunctive 
use of chlorhexidine mouthwash and gel to disinfect any bacterial reservoirs in the oral cav-
ity), local antimicrobials (i.e., disinfectants such as chlorhexidine and locally delivered anti-
biotics or antiplaque mouthwashes) which have bacteriostatic and bactericidal activity and 
can inhibit the development of gingivitis, but despite this proved effect, they have a much 
reduced effect on established plaque and cannot prevent the progression of periodontitis [14], 
and systemic antibiotics (which are prescribed as an adjunct to root surface instrumentation) 
have been proposed to act by suppressing the bacterial species responsible for biofilm growth, 
leading to a less pathogenic oral environment [15].
(4) Management of acute conditions should be made as much as possible by local treatment, 
avoiding the use of systemic antibiotics if there is no significant sign of infection. The main 
acute conditions that may be associated with periodontal disease refer to periodontitis associ-
ated with endodontic lesions (which is a combined perio-endo lesion characterized by clini-
cal attachment loss but also a tooth with a necrotic, or partially necrotic, pulp), periodontal 
abscess (occasionally occurring in patients with periodontitis, characterized by localized pain 
and swelling due to nondraining infection of a periodontal pocket), and necrotizing ulcerative 
gingivitis and periodontitis (characterized by marginal gingival ulceration with loss of the 
interdental papillae and a gray sloughing on the surface of the ulcers) [9].
(5) Management of occlusal trauma have been linked with periodontal disease for many years, 
but the role of occlusion in the etiology and pathogenesis of inflammatory periodontitis is still 
not completely understood [16].
(6) Management of dentine sensitivity is a condition some patients may experience following root 
surface instrumentation, especially those with sensitive teeth prior to treatment. Identification 
and treatment of the causative factors of dentine sensitivity help to prevent the condition from 
occurring or recurring. There are various treatment modalities available which can be used at 
home or may be professionally applied, such as toothpastes, mouthwashes, or chewing gums, 
and they act by either occluding the dentinal tubules or blocking the neural transmission [17].
(7) Host modulation therapy aims to modulate the destructive aspects of the host’s immune-
inflammatory response to the microbial biofilm by utilizing the anti-inflammatory drugs or 
oral products (i.e., sub-inhibitory doses of tetracycline). This approach has led to the emer-
gence of a new field of “Perioceutics” which is based on the use of pharmaco-therapeutic 
Impact of Dental Plaque Biofilms in Periodontal Disease: Management and Future Therapy
http://dx.doi.org/10.5772/intechopen.69959
15
agents including antimicrobial drugs, as well as host modulatory therapy for the manage-
ment of periodontitis. These host-modulating agents could be successfully used as adjunct 
components to the balance between periodontal health and disease progression in the direc-
tion of a healing response [18].
(8) Dental prophylaxis refers to various approaches including plaque elimination by regular 
tooth brushing, periodical professional removing of mineralized dental plaque or tartar, oral 
examination and evaluation of periodontal disease progression [19].
2. Oral microbiota: host interactions
In 2001, Joshua Lederberg introduced the term microbiome signifying “the ecological com-
munity of commensal, symbiotic, and pathogenic microorganisms that literally share our 
body space and have been all but ignored as determinants of health and disease” [20]. These 
complex communities of microbes and their genes play a fundamental role in controlling the 
host physiology (metabolism, nutrition, immune system development, regulation of gastro-
intestinal and cardiovascular systems, etc.) [21] and also support the innate and adaptive host 
defenses in excluding exogenous (and often pathogenic) microorganisms [22]. The healthy 
microbiome in any individual patient has relatively lower taxonomic diversity, remaining 
relatively constant over time, this natural balance being termed “microbial homeostasis,” but 
its exact composition differs significantly across individuals [23].
The healthy state is highly regulated by the host immune system, and interactions between the 
microbial community members and with the host maintain a community dominated by “good” 
microbes, usually gram-positive Actinobacteria or streptococci (Figure 2) [24].
2.1. Host defense mechanisms
Host defenses play an important role in maintaining the homeostasis of the oral cavity. The 
alliance between the immune system and oral microbiota is responsible for the maintenance 
of tolerance to microbial antigens, the host monitoring and responding permanently to the 
colonizing microorganisms. Any changes in this symbiotic relationship induced by antibiot-
ics, diet, and elimination of normal microbiota constitutive species increase the risk for auto-
immune and inflammatory disorders [21].
Regarding the prenatal development of cellular components associated with the oral mucosa 
associated immune system, it was observed that the initial organization of Peyer’s patches 
can be immunohistologically detected at 11 weeks of gestation [25]. Epithelial cells positive 
for the secretory component of the sIgA and immunocytes positive for IgM can be detected 
in salivary gland tissue by 19–20 weeks and continue to predominate during gestation. After 
birth, immunocytes secreting IgA begin to dominate, but no IgA can be detected in saliva at 
birth. sIgA was detected in the neonates’ saliva as early as 3 days after birth, and its concentra-
tion increased more rapidly during the first 6 months after birth in infants exclusively breast 
fed [26]. Salivary IgA in young infants has the molecular characteristics of secretory IgA and 
predominates in saliva. Both IgA subclasses are present in the proportions  characteristic of 
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adult in 1- to 2-month-old infants, although the appearance of IgA2 is delayed in some sub-
jects [27]. The infant apparently can activate mucosal immune responses quite early in life. For 
example, salivary antibody specific to organisms that originally colonize the oral cavity (e.g., 
S. mitis, S. salivarius) can be detected by 1–2 months of age. Most of these antibodies are sIgA, 
although some IgM antibodies can also be initially detected. Salivary sIgAl and sIgA2 specific 
to S. mitis and S. salivarius components increase qualitatively and quantitatively during the 
first few years of life [28]. Salivary IgA specific to components of streptococci that require 
hard surfaces for colonization (e.g., S. sanguis and mutans streptococci) generally appear after 
tooth eruption [29]. The maternal placental–derived IgG with specificity toward oral micro-
biota is replaced by the de novo synthesis stimulated by the teething process. The collective 
contributions in the oral cavity of innate and antibody-based immune elements from the 
saliva, gingival crevicular fluid (and milk if breast feeding) may be considered together with 
diet, infectious dose, salivary receptors, and tooth integuments, as factors that can determine 
the outcome of initial colonization events on erupting tooth surfaces [25].
Saliva plays an important role in maintaining the oral homeostasis, through the flushing effects 
and its antimicrobial constituents like mucin, lysozyme, lactoferrin, salivary peroxidase, and 
histidine-rich proteins, which are all components of innate immunity [25]. Moreover, local con-
centrations of these proteins near the mucosal surfaces, periodontal sulcus (gingival  crevicular 
Figure 2. The microbiota plays a fundamental role on the induction, training and function of the host immune system, 
the interactions between mucosal surfaces and microbiota accomplishing a key role in host defense, health and disease.
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fluid), and oral wounds reinforced by immune and/or inflammatory reactions of the oral mucosa 
are primarily responsible for innate immunity [30]. Lysozyme is a hydrolytic enzyme that cleaves 
the carbohydrate components of the cell wall peptidoglycan, resulting in cell lysis. This enzyme 
is active against both gram-negative and gram-positive microorganisms; its targets include 
Veilonella species and Actinobacillus actinomycetencomitans [30]. Lactoferrin is an iron-binding glyco-
protein that links to free iron in the saliva, causing bactericidal or bacteriostatic effects on various 
microorganisms requiring iron for their survival. Lactoferrin also provides fungicidal, antiviral, 
anti-inflammatory, and immunomodulatory functions [31–33]. The lactoperoxidase-thiocyanate sys-
tem in saliva has been shown to be bactericidal on some strains of Lactobacillus and Streptococcus 
by preventing the accumulation of lysine and glutamic acid, both of which being essential for 
bacterial growth [34, 35]. The histatins, a family of histidine-rich peptides, have antimicrobial activ-
ity against some strains of Streptococcus mutans and inhibit hemagglutination activity of the peri-
odontopathogenic P. gingivallis. Also, they neutralize the lipopolysaccharides of gram-negative 
bacteria and exhibit fungicidal activity against several Candida species, Aspergillus fumigatus, some 
strains of Saccharomyces cerevisiae, and Cryptococcus neoformans [36, 37]. Some defense proteins, 
like chaperones HSP70/HSPAs (70 kDa heat shock proteins), are also involved in both innate 
and acquired immunity [30]. In addition, saliva contains abundant CD14 amounts from salivary 
glands in a soluble form, although LPS-binding protein was below detectable levels, suggesting 
that saliva CD14 is important for the maintenance of oral health [38].
Gingival crevicular fluid (GCF) is a fluid coming from the junctional epithelium of the gingiva 
that carries all key molecular (complement components and antibodies, K, Na–electrolytes, 
enzymes and enzymes inhibitors) and cellular (neutrophils and plasma cells) components 
of the immune response that are necessary to prevent tissue invasion by subgingival plaque 
bacteria [39, 40]. Composition of the GCF is the result of the interaction between bacterial 
biofilm adherent to the tooth surfaces and the cells of the periodontal tissues [41]. The GCF 
induces permanently changes in microbiota composition, playing an important role in the 
introduction of immune cells, and being a source of nutrients for resident microorganisms. A 
number of enzymes can be detected in GCF, including collagenases and elastases which are 
derived from phagocytic cells and are responsible for the destruction of gingival tissues [42]. 
Therefore, GCF components might serve as potential diagnostic or prognostic markers for the 
progression of periodontitis [23, 39]. Although the presence of cytokines was highlighted in 
GCF, there is no clear evidence of their involvement in the disease. However, interleukin-1 
(IL-1) alpha and IL-1 beta are known to increase the binding of PMNs and monocytes to endo-
thelial cells, stimulate the production of prostaglandin E2, release of lysosomal enzymes and 
bone resorption. On the other hand, interferon (IFN) alpha present in GCF has a protective role 
in periodontal disease because of its ability to inhibit bone resorption activity of IL-1 beta [43].
Mucosal epithelial cells play an integral role in innate immune defense by sensing signals 
from the external environment, generating various molecules to affect growth, development, 
function of other cells and maintaining the balance between health and disease [44]. Mucosal 
epithelial cells produce antimicrobial peptides that include the β-defensin family, cathelicidin 
(LL-37), calprotectin, and adrenomedullin. These epithelial antimicrobial peptides are impor-
tant for wound healing and cell proliferation or exert chemotactic effect to immune cells [45]. It 
is now recognized that the antimicrobial peptide hBD-2 found in the supra-basal layer of epithe-
lium, stimulates antigen-presenting dendritic cells that signal the adaptive immune  system, in 
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 addition to its antimicrobial activity [44, 46]. Also, it has been proposed that LL-37, the only anti-
microbial peptide from the cathelicidin family, detected in gingival epithelium may be the prod-
uct of neutrophils migrated through gingival epithelium rather than epithelial cells themselves 
[47]. LL37 is active against both gram-negative and gram-positive bacteria including established 
periodontopathogens, like P. gingivalis and A. actinomycetemcomitans [48].
Calprotectin is constitutively produced by neutrophils, monocytes, macrophages, and epithe-
lial cells, its levels being positively correlated with the severity of periodontitis in GCF [49]. 
The antimicrobial activity of calprotectin is provided by its ability to bind calcium, zinc, cop-
per, and manganese ions. These ions are essential for usual microbial functioning; thus, calpro-
tectin is a growth inhibitory type of host defense [50].
Oral mucosal cells such as epithelial cells are thought to act as a physical barrier against the 
invasion of pathogenic organisms, but they have also the ability to produce inflammatory 
cytokines and express adhesion molecules. Gingival tissue of clinically healthy human also 
expresses low levels of a wide range of toll-like receptors (TLRs), including TLR1-TLR9 that 
mediate the response to a broad range of microorganisms [51, 52]. However, oral epithelial 
cells are refractory to many bacterial components, although they express toll-like receptors/
MyD88 and acquire responsiveness after priming with IFN-gamma. When the cells are stimu-
lated with lipopolysaccharides and neutrophil protease (PR3) after IFN-gamma priming, the 
cells produce interleukin 8 (IL-8), which is critical to Th1 and Th2 responses. PR3 itself is able to 
activate the cells through G protein-coupled protease-activated receptor-2 on the cell surface.
Also, gingival fibroblasts are well equipped to respond to bacterial components and may 
contribute to the IL-8 levels observed in clinically healthy tissue [53]. Studies in germ-free 
mice show that there are low levels of innate immunity mediators present in the periodontal 
tissue [54, 55], indicating that a basic level of cytokine expression is genetically programmed, 
without bacterial challenge. Any changes of dental plaque composition modify cytokine 
expression [54, 56]. As an example, an in vitro study is showing that the TLR response can 
be manipulated by P. gingivalis toward two types of lipopolysaccharides: PgLPS1690 (type 
I) and PgLPS1435/1449 (type II). Type I is a TLR4 agonist, thus activating the immune sys-
tem, while type II is a TLR4 antagonist inhibiting the immune response to P. gingivalis [57]. 
The expression of these two types of LPS is regulated by the concentration of iron from 
the hemin found in the GCF [58]. During inflammatory process, P. gingivalis type II LPS 
expression increases which reduces the TLR4 response. It was proposed that this could 
facilitate survival and multiplication of the entire microbial community [59]. P. gingivalis 
can block gingival epithelial cells IL-8 production in vitro, by secreting a serine phosphatase 
that inhibits the synthesis of IL-8 [60]. This process can delay the recruitment of neutrophils 
preventing the proper formation of the neutrophil wall, facilitating initial microbial coloni-
zation of the periodontium [61]. Other bacteria such as T. denticola are also able to manipu-
late the interleukin response of the host by yet not understood mechanism(s) [62].
2.1.1. Neutrophils
The primary function of both nonspecific and specific mucosal immunity is to protect the teeth, 
jaws, gingiva, and oral mucosa against infection. In healthy individuals, periodontal tissue 
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contains a wall of neutrophils, between the plaque and the epithelial surface, and cellular infil-
trate located in juxtaposition to the colonized tooth surface, closest to the dental plaque bio-
film [63]. Expression of mediators such as interleukin 8 (IL-8), intercellular adhesion molecule 
(ICAM), E-selectin and β defensin molecules 1, 2 and 3 are required to form this neutrophil 
defense wall [64–66]. E-selectin is required for neutrophil migration from the highly vascular-
ized gingival tissue, IL-8 is a key neutrophil chemo-attractant produced by epithelial cells, and 
ICAM facilitates adhesion of neutrophils to the tissue allowing formation of this wall [67, 68].
2.1.2. Complement system
The complement system is a major component of the innate immune response involved in 
recognizing and destroying microorganisms, with complex roles in homeostasis and disease. 
Activated complement fragments are abundantly found in the GCF of periodontitis patients, 
whereas they are absent or present in lower concentrations in healthy individuals [69, 70]. To 
be a successful pathogen in humans (and any other mammal), a microorganism needs to be 
able to avoid complement-mediated detection and killing. In vitro studies have shown that 
periodontal bacteria, such as P. gingivalis, T. denticola and Prevotella intermedia could interact 
with the complement system in complex ways that either inhibit or activate specific comple-
ment components [71]. One of the best-studied species from the oral cavity is P. gingivalis 
that produces membrane bound and soluble arginine-specific cysteine proteinases called 
“gingipains” that can destroy complement factors (C3 and C5) and thus render the bacteria 
resistant to the bacteriolytical activity of complement system [72, 73].
2.2. Oral microbiome dysbiosis and periodontitis
Recent discussions on the definition of general health have led to the proposal that human 
health is the ability of the individual to adapt to physiological changes, a condition known 
as allostasis [74]. The allostasis in the oral cavity is a complex phenomenon, since the relation-
ship between the oral microbiome and its host is dynamic and any physiological or hormonal 
changes of the host can affect the balance of the species within these communities [75]. The 
idea that the accumulation of dental plaque is responsible for oral disease, but without dis-
criminating between the different virulence levels of bacteria, has led to the “Non-Specific 
Plaque Hypothesis” [76]. The two most common oral diseases, caries and periodontal disease, 
are highly abundant among the population of industrialized countries, having a major impact 
on the populations’ well-being and healthcare providers [77].
The factors responsible for the transition from periodontal health to either gingivitis or peri-
odontitis are the acquisition of certain species/combinations of species (Table 1) and less than 
optimal host response, which in extreme cases removes the local environment by causing loss 
of dentition to protect the host from life-threatening bacterial infections [78]. Although the peri-
odontal disease microbiomes are more diverse in terms of community structure, that structure 
is quite similar across different patients [79]. Gingivitis is associated with an increased microbial 
load (104 to 106 organisms) and a corresponding increase in the percentage of gram-negative 
organisms (15–50%) [80]. An interesting finding is that the microbiota of older subjects, with 
no prior history of gingivitis, had up to 45% gram-negative species including Fusobacterium 
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nucleatum, P. gingivalis, P. intermedia, Campylobacter rectus, Eikenella corrodens, Leptotrichia, and 
Selenomonas species, demonstrating that an individual is more likely to carry gram-negative 
bacteria and periodontal pathogens in healthy sites with increasing age [59, 81]. It is likely that 
the presence of these periodontal pathogens in healthy sites alters the host response, rendering 
these sites more susceptible to active disease in the future.
The microbiota associated with periodontal disease seems to display a significant enrichment 
in specific metabolic pathways, compatible with an oxygen poor environment, and the avail-
ability of amino acids and lipids as major carbon and nitrogen sources [82]. The unbalanced 
microbiota is rich in lipid-degradation pathways, as well as other known virulence-related 
activities, such as lipopolysaccharide (LPS) biosynthesis with local inflammatory effect [83].
The presence of pathogens within this community can lead to the clinical manifestations of 
periodontal disease, which in turn can lead to additional changes in the community due to the 
increased availability of nutrients released by the damaged tissue.
Although the bacteria rarely invade the tissues and cause acute infections (e.g., Prevotella 
intermedia invades both epithelial cells and macrophages), they could release substances that 
penetrate the gum and directly causes the tissue destruction by the enzymes and endotoxins 
action or indirectly through the induction and maintenance of the chronic inflammatory pro-
cess, leading to the progressive destruction of collagen in the connective tissue that hold teeth 
in the gum [84, 85]. The presence of P. gingivalis and high colonization by A. actinomycetem-
comitans, T. denticola and P. intermedia plays an important role in severe periodontitis.
The presence of P. gingivalis in the dental plaque biofilm results in the inhibition of compo-
nents of the innate host defense system. This is caused by the lack of IL-8 that normally guides 
leukocytes to the site of bacterial colonization. In addition, E-selectin that facilitates leukocyte 
Table 1. The specific composition of subgingival bacterial plaque in gingivitis and periodontitis.
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exit from the vasculature into surrounding tissue is absent. The local inhibition of these inflam-
matory mediators results in the lack of sufficient leukocytes to properly control dental plaque 
growth, proposed to be one of the major factors in the development of periodontitis. Also, it 
has been demonstrated that individuals co-infected with T. denticola and P. intermedia were 
more likely to have periodontitis than were those infected with a single pathogen [86].
Gram-negative bacteria in particular are known to release large amounts of cell wall material 
as outer membrane vesicles containing lipopolysaccharide, lipid and protein that are believed 
to represent a normal mechanism of membrane turnover. In addition, the release of mem-
brane vesicles and cell wall fragments serves to protect bacteria in the biofilm by acting as 
decoys that bind and activate innate host defense components (i.e., alternative pathways of 
activation of complement system) and that would otherwise bind to the surface of viable 
bacteria and kill them; in the same time, the total amount of LPS and the consecutive inflam-
matory effect are increasing [59].
Lipopolysaccharide has been reported to pass through an intact epithelial cell barrier and 
concentrate around blood vessels in the lamina propria, interacting with nearly all cell types 
present in the periodontium, inducing a large increase in the numbers of leukocytes, espe-
cially neutrophils, in the sulcus or pocket, causing ulcerations [87]. At an early stage, the infil-
trate is dominated by B and T (Th1 and Th2) lymphocytes. Subsequently, the lesion becomes 
dominated by B cells, and less T cells, macrophages and neutrophils, all of which becoming 
activated. As the disease worsens, periodontal pockets deepen, the components of the extra-
cellular matrix of the gingiva and periodontal ligament are destroyed, and alveolar bone is 
desorbed [88]. On the other hand, bacterial LPS can subsequently interact with macrophage 
or dendritic cell receptors, including CD14 and TLRs, to stimulate the production of inflam-
matory cytokines, especially IL1, and other proinflammatory mediators [89].
The collagen and other components of the perivascular extracellular matrix are destroyed, by 
the release of lysosomal enzymes by phagocytes and the production of cytokines that stim-
ulate the release of metalloproteinases (including collagenase) by connective tissue cells or 
cytokines that activate bone resorption [90]. Four distinct pathways may be involved with this 
destruction: plasminogen dependent, phagocytic, osteoclastic and matrix metalloproteinase 
(MMP) pathway which is the most prevalent, as revealed by the larger amounts of collagenase 
and gelatinase (MMP1, MMP2, MMP9, and MMP13) found in the crevicular gingival fluid of 
patients with periodontitis [91–93]. Cleavage of collagen I by MMP13 seems to be the initial 
step of the entire bone resorption process [94, 95], and subsequently, denatured collagen frag-
ments are also degraded by gelatinases, MMP2 and MMP9 [96].
Several species, in the subgingival plaque constitution, produce volatile fatty acids (butyrate, 
propionate, and isobutirat) and peptide N-formyl-methionyl-leucyl-phenylalanine, as sulfide 
ions, hydrogen sulfide, and methyl mercaptan with cytotoxic effect on endothelial cells and 
gingival fibroblasts [97, 98].
The bacterial products and epithelial response activate perivascular mast cells to release his-
tamine that activates vascular endothelial cells to release IL-8 within the vessels to assist in 
localizing neutrophils. B and T lymphocytes are activated by antigens or unspecific mitogens to 
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proliferate and give rise to clones of effector cells; B cells are driven to differentiate into clones 
of antibody producing plasma cells [99, 100]. Bacterial material released in the periodontium 
provides thus a major form of communication between dental plaque and the host [78].
Bacteria could activate myeloid cells (e.g., monocytes or neutrophils) to elicit IL-1, and this 
cytokine then activates a nonmyeloid cell (e.g., fibroblasts, endothelial, or epithelial cells) to 
secrete additional inflammatory mediators, interleukins 6, 10 and 12, tumor necrosis factor 
alpha, prostaglandin E2, interferon gamma, and a series of chemotactic substances: monocyte 
chemoattractant protein, macrophage inflammatory protein, and RANTES (regulated on acti-
vation, normal T-cell expressed, and secreted) [88, 101].
After the trend of 1950s and early 1960s, when periodontal treatment was based on the non-
specific plaque hypothesis, criteria for defining periodontal pathogens have been developed.
In periodontal disease, the precise identification of certain organisms (e.g., a particular 
clone (JP2) of Aggregatibacter actinomycetemcomitans) is required to identify the risk factors 
for localized aggressive periodontitis in young adults. Taking into account the difficulties 
of periodonto-pathogen cultivation, new techniques have been developed in order to detect 
bacterial species associated with periodontal disease: PCR-based methods in single or multi-
plexed approaches, sequencing 16S rRNA gene fragments or a housekeeping gene, next-gen-
eration sequencing [102]. Now, the Human Oral Microbiome Database project is undergoing, 
which aims to catalog all bacterial species found in the oral cavity. However, the molecular 
techniques are limited to the detection of a selected number of pathogens, so other important 
disease factors arising from the deregulation of the local host response could be missed [103].
3. Mechanisms of dental plaque resistance to antimicrobials and 
strategies to fight them
Dental plaque displays properties that are typical for biofilms, being structurally and func-
tionally organized polyspecific communities embedded in an extracellular matrix of exopoly-
mers on mucosal and dental surfaces [104], functionally organized and benefiting of increased 
metabolic efficiency, pathogenic synergism and enhanced virulence, greater resistance to host 
stress factors and tolerance to all kind of antimicrobials [105].
Resistance to antibiotics (genetic or phenotypical, due to biofilm formation) is the most impor-
tant cause of nonefficient therapy of biofilm-associated infections from the oral cavity, and it 
is multifactorial.
One of the main reasons for the antibiotics ineffectiveness against the periodontal pathogen 
bacteria is that they grow in biofilms, becoming increasingly powerful, aggressive, and dif-
ficult to destroy. The antibiotics effective doses and the minimum concentration to eradicate 
biofilms are very difficult to achieve in vivo, especially in the local treatments. Biofilm penetra-
tion by biocides or antibiotics is typically strongly hindered. To increase the efficiency of new 
treatment strategies against bacterial and fungal infections, factors that lead to biofilm growth 
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inhibition, biofilm disruption, or biofilm eradication are being sought. These factors could 
include antibiotics, e.g., chlorhexidine, triclosan, povidone-iodine active against P. gingivalis 
and F. nucleatum biofilms [106]—azithromycin and other macrolides could block quorum sens-
ing mechanism and the alginate polymer formation [107].
The widespread use of antibiotics has evolutionary and ecological consequences, leading to 
the recruitment of more genes into the resistome and mobilome, with adverse consequences 
for human welfare [108], so new approaches are urgently needed to help regain control over 
infectious diseases, including periodontal disease.
There are theories which support that horizontal gene transfer of resistance determinants can 
occur in the oral biofilm [109–112]. This strongly suggests that exchange of mobile genetic ele-
ments between commensals and pathogenic bacteria can contribute to the emergence of drug 
resistance in the oral cavity. Oral microbiota exhibits different resistance mechanisms, pre-
sumably due to the complex microbial interactions and the genetic fluidity in oral biofilms. 
The possibility of conjugation among oral bacteria using an erythromycin-resistant (Erm) 
shuttle plasmid, from T. denticola to S. gordonii, was revealed [112].
Amoxicillin and penicillin resistance have been described in Veillonella sp., Fusobacterium, and 
Prevotella denticola isolated from root canals [113, 114]. High levels of penicillin resistance have 
been demonstrated in the α-hemolytic streptococci (Streptococcus mutans, S. salivarius, S.oralis, 
and S. mitis) and represent a cause for concern.
Generally, the α-hemolytic streptococci are very highly resistant to cephalosporins; 
Enterococcus sp. isolated from root canal exudates patients with periodontal lesions revealed 
high-level of cephalosporins resistance [115]. In contrast, Kuriyama et al. found that the 
genera Porphyromonas and Fusobacterium showed susceptibility to all cephalosporins, while 
Prevotella species were highly resistant [114].
Mechanisms of metronidazole resistance include mutations in the enzymes responsible for 
reduction of the antibiotic to its active form, mutations resulting in decreased entry of the 
antibiotic into the cell and mutations in transporters causing the efflux of the antibiotic. These 
mechanisms have been demonstrated in different species, e.g., Lactobacillus sp., Gemella morbil-
lorum, Actinomyces israelii, Clostridium butyricum, Eikenella corrodens, and A. actinomycetemcomi-
tans [116]. Four genes, nimA, nimB, nimC, and nimD, chromosomal or plasmid located, able 
to confer moderate to high-level metronidazole resistance have been revealed in Bacteroides 
sp. [117].
Mechanisms of tetracycline resistance include efflux proteins, production of ribosome protec-
tion proteins, and enzymatic modification of the antibiotic. Tetracycline resistance is encoded 
by tet genes. Antibiotic profiling of α-hemolytic streptococci isolated from the oropharynx 
of healthy Greek children showed a high percent of tetracycline resistant isolates [118], the 
majority of isolates being represented by S. mitis. Okamoto et al. [119] studied the prevalence 
of tetQ gene in genus Porphyromonas and Prevotella sp. They have been demonstrated that 
tet(M) represented the most common gene, which encodes a ribosomal protection protein, 
carried on Tn916/Tn1545-like conjugative transposons in Streptococcus sp., Granulicatella sp., 
Veillonella sp. and Neisseria sp., from the oral cavity [120].
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Resistance to erythromycin is commonly conferred by the acquisition of erm gene, antibi-
otic inactivation by an enzyme encoded by mph, and efflux of macrolides by an ATP-binding 
transporter encoded by msrA expressed by S. aureus isolates [116]. Low-level macrolide resis-
tance in the oral microbiota may also be associated with the expression of genes from the mef 
family, encoding another efflux pump, and recently have been found on a conjugative trans-
poson Tn1207.3 in Streptococcus pyogenes [121]. There have been described [122] erythromycin-
resistant α-hemolytic streptococci, such as S. oralis, S. salivarius and S. sanguis in healthy Greek 
children. P. intermedia isolates carried erm(F) alone or tetQ alone, but in other oral anaerobes, 
macrolide resistance often occurred in conjunction with tetracycline resistance. In Gemella 
sp. and commensal viridans streptococci isolates from oral cavity, macrolide resistance was 
associated with the aphA-3 gene [123].
There are studies which support that the resistance to chlorhexidine resistance in Streptococcus 
mutans and S. sobrinus isolates from dental plague is plasmid-mediated [124, 125].
Bacteria growing in biofilms often exhibit differing phenotypes compared with their coun-
terpart, respectively planktonic or free cells. There have been described numerous mecha-
nisms for the differences in antibiotic susceptibilities in biofilms relative to planktonic state 
growth cells. Among these, there have been demonstrated by several studies that oxygen 
limitation [126], antibiotic penetration into the biofilm [127], the presence of persister cells 
[128], biofilm-associated cells that grow significantly more slowly than planktonic cells and, 
as a result, take up antimicrobial agents more slowly [83], and also the maturity of the bio-
film might also be important contributors to increased resistance. Results of previous studies 
have demonstrated also other important mechanisms responsible for resistance to antibiotics 
[129]: biofilm growth is associated with an increased number of mutations, leading to genera-
tion of antibiotic-resistant phenotypes of bacteria, and genes involved in antibiotic resistance 
are correlated with biofilm phenotype [130]; the production of the exopolysaccharide matrix 
contributes to an increased cell survival by slowing down antimicrobial diffusion speed; and 
the differences in metabolic activity among bacteria. It has been revealed that slow-growing 
and nongrowing bacteria contribute to increased biofilm resistance to antibiotics [131]. The 
up-regulation of efflux pump proteins and activation of quorum sensing systems reduces and 
neutralizes incoming antibiotics.
Altered gene expression represents another difference between bacteria grown in biofilms 
compared with planktonic cells. There are numerous genes that are either positively or nega-
tively regulated by the complex regulatory networks, efflux pumps when the bacteria are 
growing as a biofilm compared with planktonic cultures [132, 133].
Numerous plants are used in traditional medicine against various diseases. Furthermore, 
plant extracts have pronounced antimicrobial activities when used at sub-inhibitory con-
centrations, which are usually very low concentrations with minimal or no effect against 
host cells. Using sub-inhibitory concentrations of an antimicrobial compound, namely 
concentrations which do not interfere with bacteria growth, but only with their behav-
ior, leads to reduced risk of developing resistance to that compound. The most recent 
strategies propose the targeting of communication control, as QS signaling, since quorum 
sensing is not an essential process, and QS mutants in general have not displayed growth 
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defects, but this signaling controls virulence and biofilms. The quorum sensing mecha-
nism involves the production, release and detection of chemical signaling molecules, 
which permits communication between microbial cells and gene expression regulation 
in a cell-density-dependent manner. Granted, interfering with the regulation of virulence 
factor production developing resistance mechanisms against quorum-inhibiting therapies, 
may be a difficult proposition for bacteria, which could help promote long-term efficacy of 
anti-QS therapies [134].
Recent studies revealed that numerous plant-derived compounds and essential oils (EOs) 
exhibit increased antimicrobial properties, by interfering with QS controlled phenotypes such 
as adherence, biofilm, formation, motility and pigment production, affecting also antibiotic 
susceptibility, or revealing microbiostatic properties [135–137]. Not only plant extracts, but 
also propolis extracts have proved to possess a broad spectrum activity against various gram-
positive and gram-negative bacteria: Staphylococcus spp., Streptococcus spp., Listeria spp., 
Bacillus spp., Enterobacteria (Klebsiella pneumoniae, Escherichia coli), Pseudomonas aeruginosa, and 
Helicobacter pylori [138, 139]. The antibacterial activity of propolis is mainly correlated with 
caffeic acids, flavonoids, phenolic esters, and aromatic compounds [140].
Relatively few research works on propolis ability to inhibit biofilm formation have been 
published. Duarte et al. have shown that propolis inhibits the growth of oral microorgan-
isms and the activity of bacteria-derived glucosyltransferases (GTFs), responsible for glucan 
synthesis which favors bacterial adhesion and plays an essential role in the development 
of pathogenic dental plaque [141]. Bulman et al. showed that propolis contains compounds 
that inhibit signaling mediated by N-acyl-homoserin-lactone in Pseudomonas aeruginosa PAO1 
[142]. Our studies have shown that the 30% Romanian propolis tincture presented antibacte-
rial activity toward S. aureus, E. coli, K. pneumoniae and P. aeruginosa, and antibiofilm activity 
against S. aureus) [139]. Associated with the use of some antibiotics, the efficacy and duration 
of propolis extract action is more pronounced, and these organisms do not develop antibiotics 
resistance, as demonstrated for dexpanthenol associated with propolis against P. aeruginosa 
and S. aureus strains isolated from infected wounds.
These data confirm that natural extracts have anti-QS, antiseptic, and antivirulence proper-
ties and can easily inhibit biofilm formation as well as disrupt the mature biofilm structure. 
Thus, plant and/or bee extracts in combination with other antimicrobial strategies could 
provide an effective microbicidal tool for the treatment of various bacterial and yeast infec-
tions. However, due to difficulties in cultivating anaerobic periodontal pathogens, there are 
only few studies concerning the efficiency of vegetal extracts against periodontal pathogenic 
strains. Chifiriuc et al. (2009) demonstrated that usnic acid selectively inhibited the biofilm 
development by Gram-positive bacteria and the expression of hemolytic properties of strains 
isolated from the dental plaque [143].
It has been shown that mouthwash with essential oils (EO) might be a reliable alternative 
to chlorhexidine (CHX) for controlling gingival inflammation, dental plaque development, 
bacteremia with anaerobic bacteria in patients with mild-to-moderate gingivitis and oral 
malodor [144, 145]. Moreover, the diluted EO displayed no detectable detrimental effects on 
human gingival and periodontal ligament fibroblasts, while diluted CHX reduced both cell 
migration and long-term survival [146]. The regular long-term use of the EO-based mouth 
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rinse improved the efficacy of a 0.05% cetylpyridinium chloride- and fluoride-containing 
mouth rinse [144]. Linalool and α-terpineol exhibited strong antimicrobial activity against 
periodontopathic and cariogenic bacteria [147]. Salvadora persica root stick extracts and its 
active component benzyl isothiocyanate are very efficient against oral pathogens involved 
in periodontal disease as well as against other gram-negative bacteria [148]. The adjunctive 
use of EO has been shown to promote significant clinical attachment level gain and probing 
pocket depth reduction in deep residual pockets [149]. A gel containing 10% Lippiasidoides 
(LS) was evaluated and has been shown to reduce plaque, bleeding, and gingival index within 
the experimental period of 21 days [150].
These scientific data suggest that the antibiofilm compounds should be used in various com-
binations, in order to develop innovative early combinatory strategies [151] which may poten-
tially strongly support classical treatments and cause an increase of their effectiveness in case 
of chronic infections, such the periodontal ones.
Other strategies in the improvement of the biological activity used in the management of peri-
odontal diseases are based on the encapsulation of therapeutic drugs in appropriate shuttles. 
Drug delivery by liposomes with different encapsulated bioactive molecules (such as bac-
teriocins, enzymes, antiseptics, antibiotics, and vegetal compounds) can assure a controlled 
delivery of some antimicrobial substances at infection’s situs, with a great efficiency in dental 
caries and every other biofilm-associated infection [152]. Encapsulation technologies, which 
may shield substances such as nisin from degradation by digestive enzymes and effectively 
deliver the encapsulated contents at the same time, represent new direction in the field of 
preventive medicine [153].
4. Future perspectives for the therapeutic management of periodontitis
Despite numerous current approaches, periodontitis still remains one of the most common 
disease, causing moderate-to-very-severe health damage and complications in a high num-
ber of individuals. Perspectives for future and advanced therapies aiming for efficient man-
agement of periodontal conditions flourished in the last decade, and the recent progress in 
science and technology made possible a wide range of novel approaches to be successfully 
applied.
4.1. Periodontal tissue regenerative therapy
This approach was formulated in 1993 by Langer, who proposed tissue engineering as a pos-
sible technique for regenerating lost periodontal tissues. This rapidly emerging research field 
represents the interface between materials science and biocompatibility and integrates cells, 
natural, or synthetic scaffolds, and specific signals to obtain new tissues [154].
Tissue engineering applied for bone and periodontal regeneration combines three key ele-
ments to enhance regeneration: use of progenitor cells, design of scaffolds or support-
ing matrixes, and selection of suitable signaling molecules. Cell sources of progenitor cells 
may be represented by periodontal ligament-derived cells, periodontal ligament-derived 
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 mesenchymal stromal cells, periosteal cells, gingival epithelium and fibroblast cells but also 
bone marrow–derived mesenchymal stem cells [154].
Scaffolds and supporting matrices are required to offer a three-dimensional (3D) support 
and assist periodontal tissue regeneration. These structures have important roles, such as: 
(1) suitable framework, which maintains the shape of the defect; (2) physical support for the 
healing area, so that there is no collapse of the surrounding tissue into the wound site; (3) 
3D substratum for cellular adhesion, migration, proliferation and production of extracellular 
matrix; (4) selective barrier to restrict cellular migration; and (5) delivery vehicle for growth 
factors and differentiation molecules [154]. Biomaterials utilized for efficient scaffolds are 
very diverse, and they may be included in various categories, such as: ceramics (i.e., hydroxy-
apatite, beta tricalcium phosphate), polymers (i.e., synthetic: polyglycolic acid, polylactic acid 
and polycaprolactone; natural: collagen fibrin, albumin, hyaluronic acid, cellulose, chitosan, 
polyhydroxyalkanoates, alginate, agarose, polyamino acids, etc.), and synthetic polyesters 
(i.e., polyglycolic acid, polylactic acid and polylactic-co-glycolic acid) [155].
In order to increase efficiency, regenerative therapy relies on the incorporation of various 
bioactive molecules into scaffolding materials, to improve cellular development and tissue 
healing. The incorporation of specific bioactive molecules within the scaffold is aiming to 
ensure a sustained and controlled release of bioactive molecules for longer periods of time. 
These bioactive molecules can be incorporated directly into the scaffolding material or with 
along with a delivery vector, which ensures its stability and controlled release.
The most utilized bioactive molecules to be integrated in scaffolds designed for periodontal 
tissue regenerative therapy are as follows: platelet-derived growth factor (potent media-
tor of periodontal tissue regeneration, currently approved for the treatment of periodontal 
defects—commercially available as Gem-21 (Osteohealth, Shirley, NY)); fibroblast growth 
factor (which has a profound effect on periodontal soft tissue and bone healing and also stim-
ulates angiogenesis) [156]; bone morphogenetic proteins (disulfide-linked homodimer that 
promotes periodontal healing) [157]; insulin-like growth factor (which has mitogenic effects 
on periodontal ligament fibroblastic cells and can stimulate the synthesis of DNA in peri-
odontal ligament fibroblasts) [158]; transforming growth factor beta (act as bone coupling 
factor linking bone resorption to bone formation) [159]; and periodontal ligament-derived 
growth factor (it is a highly specific autocrine chemotactic agent for human periodontal 
ligament cells, which is 1000-fold more potent than many known growth factors, and has 
no chemotactic effect on gingival fibroblast or epithelial cells, thereby promising its utility 
for biological therapeutic regime needed for cell-specific periodontal regeneration) [159].
Recent progress in tissue engineering has allowed the delivery of such molecular factors by vari-
ous means. Gene therapy and nano-delivery represent the most investigated approaches for the 
delivery of bio-active molecules, useful for regenerative medicine applied for periodontal disease.
4.2. Gene therapy
Gene therapy presents certain advantages when compared to other therapies. Because both 
cell transplantation and laboratory cell culturing are not needed, gene therapy may be safer 
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and more cost-effective than cell-based therapies [154, 160]. Platelet-derived growth factor 
and bone morphogenetic proteins are the most utilized for delivery in periodontal regen-
erative therapy. Plasmid and circular vector-based delivery of platelet-derived growth factor 
proved safety favorable characteristics for clinical use. Moreover, the expression of platelet-
derived growth factor genes was prolonged for up to 10 days in gingival wounds, when 
administered through this approach. It seems that continuous exposure of cementoblasts to 
platelet-derived growth factor has inhibitory effect on cementum mineralization, possible via 
the upregulation of osteopontin and subsequent enhancement of multinucleated giant cells in 
cementum-engineered scaffolds [161].
The delivery of genes that encode the bone morphogenetic proteins stimulate the formation 
of periodontal tissue formation. Moreover, the expression of this gene promoted successful 
regeneration of alveolar bone defects around dental implants [161]. Ribonucleic acid medi-
ated silencing, a novel approach, is based on the principle of RNA interference (RNAi), a 
novel mechanism of action whereby the expression of certain genes detrimental to the tissue 
regeneration process is silenced by RNAs. The first siRNA-based therapeutic tested in human 
clinical trials was the vascular endothelial growth factor (VEGF)–targeted RNA for the treat-
ment of macular degeneration of the retina. Tumor necrosis factor-α-targeted siRNA can sup-
press osteolysis induced by metal particles in a murine calvaria model, opening the way to the 
application of RNAi in orthopedic and dental implant therapy [162]. The use of RNA-based 
therapeutics for tissue regeneration is still in its early stages. Nevertheless, RNAi promises to 
be an effective therapeutic tool and may be successful in periodontal regeneration [154].
5. Conclusions
Dental plaque is a model of polyspecific biofilm, very studied mainly due to its accessibil-
ity, but also to its implications in dental caries, periodontitis, and periodontal disease—this 
one being an irreversible affection once launched, very spread in the world. It is of great 
interest for the field of dentistry and for medicine too, due to its complications, more or less 
severe, local and at distance too, infectious and noninfectious. A lot of scientific knowledge 
is accumulated, and therapeutically progresses are done in this field, but the topic still needs 
improvements and remains a challenge.
Studies have shown that almost all forms of the periodontal disease are consequences of 
the dental plaque biofilms and of chronic, nonspecific or specific bacterial infections and 
chronic inflammation too. Along with dental plaque, the occurrence of periodontal diseases 
is influenced by numerous other factors, such as the virulence and resistance mechanisms of 
involved microbial species but also host-related factors. Understanding the complex organi-
zation of dental plaque biofilms, the interactions between commensal and pathogenic species 
in this community but also the relation with the host is vital for elucidating the mechanisms 
of periodontal diseases and drawing novel therapeutic perspectives.
Although traditional preventive and therapeutic approaches relying on adequate hygiene, 
mechanical removal of the dental plaque, surgery, and antibiotic treatment are still widely 
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utilized, recent strategies propose the utilization of numerous modern techniques to specifi-
cally target particular aspects of periodontal disease. Their implementation depends on the 
extensive knowledge regarding intimate biological parameters of various periodontal condi-
tions and could be more effective in both the prevention and therapy of such diseases.
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